Mammaglobin, a potential marker of breast cancer nodal metastasis

Journal of Pathology

Volumn 189, Issue 1, 1999, Pages 28-33

  Leygue, Etienne ^a,b   Snell, Linda ^a   Dotzlaw, Helmut ^a   Hole, Kate ^a   Troup, Sandy ^a   Hiller Hitchcock, Tamara ^a   Murphy, Leigh C ^a   Watson, Peter H ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Breast cancer; Lymph node; Mammaglobin; Marker; Metastasis; Subtractive hybridization; Tumour progression; Uteroglobin

Indexed keywords

MESSENGER RNA; TUMOR MARKER; UTEROGLOBIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UTEROGLOBIN;

EID: 0032839298     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199909)189:1<28::AID-PATH389>3.0.CO;2-H     Document Type: Article

References (20)

1. Mon M, Mimori K, Inoue H, et al. Detection of micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1995; 55: 3417-3420.
2. Noguchi S, Aihara T, Motomura K, Imaoka S, Koyama H. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcription-polymerase chain reaction. Comparison between Muc-1 mRNA and Keratin-19 mRNA amplification. Am J Pathol 1996; 148: 649-656.
3. Dingemans AM, Brakenhoff RH, Postmus PE, Giaccone G. Detection of cytokeratin-19 transcripts by reverse transcription-polymerase chain reaction in lung cancer cell lines and blood lung cancer patients. Lab Invest 1997; 77: 213-220.
4. Leygue E, Watson PH, Murphy LC. Identification of differentially expressed genes using minute amount of RNA. Biotechniques 1996; 21: 1008-1012.
5. Leygue E, Snell L, Hiller T, et al. Differential expression of psoriasin mRNA between in situ and invasive human breast carcinoma. Cancer Res 1996; 56: 4606-4609.
6. Watson MA, Flemming TP. Isolation of differentially expressed sequence tags from human breast cancer. Cancer Res 1994; 54: 4598-4602.
7. Watson MA, Fleming TP. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 1996; 56: 860-865.
8. Hiller T, Snell L, Watson PH. Microdissection/RT-PCR analysis of gene expression. Biotechniques 1996; 21: 38-44.
9. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. Histopathology 1991; 19: 403-410.
10. Leygue E, Snell L, Hiller T, et al. Expression of lumican in human breast carcinoma. Cancer Res 1998; 58: 1348-1352.
11. Watson MA, Darrow C, Zimonjic DB, Popescu NC, Fleming TP. Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to chromosome 11q13. Oncogene 1998; 16: 817-824.
12. Chuaqui RF, Zhuang Z, Emmert-Buck MR, Liotta LA, Merino MJ. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. Am J Pathol 1997; 150: 297-303.
13. Nayar R, Zhuang Z, Merino MJ, Silverberg SG. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using microdissection and polymerase chain reaction. Hum Pathol 1997; 28: 277-282.
14. Fantl V, Richards MA, Smith R, et al. Gene amplification on chromosome 11q13 and estrogen receptor status in breast cancer. Eur J Cancer 1990; 26: 423-429.
15. Bieche I, Lidereau R. Genetic alterations in breast cancer. Genes Chromosome Cancer 1995; 14: 227-251.
16. Courjal F, Cuny M, Simony-Lafontaine J, et al. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumours: definition of phenotypic groups. Cancer Res 1997; 57: 4360-4367.
17. Driouch K, Champeme MH, Beuzelin M, Bieche I, Lidereau R. Classical gene amplifications in human breast cancer are not associated with distant solid metastases. Br J Cancer 1997; 76: 784-787.
18. Kerangueven F, Noguchi T, Coulier F, et al. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res 1997; 57: 5469-5774.
19. Kundu GC, Mantile G, Miele L, Cordella-Miele E, Mukherjee AB. Recombinant human uteroglobin suppresses cellular invasiveness via a novel class of high-affinity cell surface binding site. Proc Natl Acad Sci USA 1996; 93: 2915-2919.
20. Leyton J, Manyak MJ, Mukherjee AB, Miele L, Mantile G, Patierno SR. Recombinant human uteroglobin inhibits the in vitro invasiveness of human metastatic prostate tumour cells and the release of arachidonic acid stimulated by fibroblast-conditioned medium. Cancer Res 1994; 54: 3696-3699.